Member Info for Aldebaran

And IP owned until 2045 no less!

This is what i was saying. Retail get excited by non material news like extreme H buy in and then it gets sold into by the smart money. 2027 is the pivot point here if things are on track. Everything in the meantime is noise.

Suggest you take a good hard look at Avacta and Hemo while you're waiting. Both primed and have game changing cancer busting technology on verge of commercialisation

Looking good now 62p resistance has broken. I see high 80's inbound. Of course peel hunt are expecting 99p by end this month

Not angry, just find it funny that you have invested in a second rate podcast company that has no USP, runs on waifer thin margins and operates in a crowded sector and you come here pretending to be invested and subtly suggesting a placing is coming even though all the evidence points to the contrary 😅

Avacta is changing the global oncology landscape, perhaps you'll learn more about it in future on one of your little podcasts.

Jog on mate, we're not daft 🤣

"Feels to soon", theirs over 3yrs of data and partnering discussions have been ongoing since at least November last year. In recent broker notes it explicitly states discussions underway, in presentations including yesterday's the ceo made is clear that deals are only pending p1b data. Not to mention that heights bond was renegotiated and why would heights agree to that. You are talking shhhh it.

Most likely is a deal for 3rd party warhead but also so many other ways to bring in money including Royalty agreement with HCRx though it probably is to early for that.

Also, why did Richard Hughes pay the October cln early? If you cant join those dots then their is no hope

Phone trades only now lol

People clearly piling in if you ask me

I always believe price action and if we close above 1200p that is a great sign. So far looking strong to my surprise actually. Go hemo go

Notposting I was shot down for saying Vlad should have raised.

The thing is he knew of the clinical milestones, he knew the conferences would be recieved positively by investors, he knew he was in talks with JHFH & a few others for a few quid and he must have known that putting all together the share price would have risen considerably so he should have had the foresight to do a sizeable raise and put to bed any concerns about cash for at least 12 months but he hasn't and hear we are.

I just hope either a commercial deal lands before a discounted raise comes OR JHFH and his mates are willing to keep funding this company at a premium until a deal is reached or the Estonia partnership realises actual useful revenue though its still only a non binding letter of intent and it will be around 6 months in my opinion until we see anything from there (tech transfer, negotiations with governments, patient screening, negotiations and binding agreement with Celline etc.. all take time)

A ramp up in trial speed and no. Of patients will increase cash burn quite a bit i suspect so while they may have reduced head count and made some savings they'll be burning more that way. This is why I said Vlad should of done a raise recently and why its crazy to be even talking of CBR right now.

All focus should be on HG-CT-1. Getting enough data to satisfy a commercial deal before another fundraise is required.

Bella they had cash to Q1 before they sold Coris so add that on and worse cash is cash to February.

However its irrelevant as we need 13m by mid January to satisfy heights which the management team are confident in delivering through partnerships this year.

We're in the deal-making window and those with the money wanted to see more data and thats exactly what avacta are providing. No deal by end Dec, might consider selling half as its more likely a placing needed but certainly not any time soon. Its more of an issue being OUT when a commercial deal lands IMO

Bella this is WHO terminology. Read the entire RNS and it clarifies.

Also, people analysing the cash is pointless. We sold our revenue generating division. The numbers are irrelevant at this stage. Enough cash to Q1 2026 so need a deal by then which appears from the language to be truly imminent this time

Archbishop I never said human, you inferred that however I clearly said there is a huge read across from the ava6k pathfinder CLINICAL trials but no offence it seems you are to dense to understand. If you think I somehow managed to delete that human comment then we will just have to add LSE website to the list of things you're struggling to understand and i get it, it can be quite technical at times. Probably why you outsource your research here to Haywain and AI.

If you want some advice id stick to a simple business like selling tinfoil hats, something tells me you'd make a fortune selling to people on here but then again if you took advice you would have sold HEMO at 1600p and bought back for 1000p 3 days later instead of posting nonsense like this on 23rd September when the share price was 1,580

"This floor is feeling really solid. Rats and mice under the floor boards nailed in"

It seems technical Analysis another thing for your 'too hard to understand' list.

What a joke of a poster you are. 😅 🤡

Nice £5m buy today. Some serious chunk of change that

Archbishop, Avacta IS closer to commercialisation though and if you're measuring the success of a investment based on the share price movement over a 3 week period then you're every bit as much as an 1diot as I thought. 😂

Also, do you really think I dont know the difference between clinical and pre clinical results? Im not the one outsourcing my scientific research to Haywain, thats you hun. X

JHFH, ive praised Vlads workarounds, I think he's pulled several blinders with these quite honestly. It was you that pointed them out to me as well. Credit wear it is due.

I haven't mentioned avacta for ages, since I brought in here and rarely bring it up now only do I mention it when other posters try and attack it because they aren't getting anywhere insulting me so they try and go after a share they know I have sizeable holding in. Im done educating you lot on it, people like Archbishop expose and even saint Haywain just expose there ignorance when they talk about it. Im happy for these people to miss out when it does the inevitable so I don't bring it up anymore. Same as with you think im sold or short or whatever. Fine now. Im past it totally. I am here to talk about HEMO good and bad and I try to be balance that's it and I won't change.

Over next few months since you brought it up, it is going to be fantastic for both Avacta and Hemo. I believe both will have something commercial within 6months. I THINK Avactas will come by beginning of December and Hemo's will come Q1 2026 caveat if both of there science continue to impress (which im sure they will).

That said, until news on both shares drops then both are at the mercy of traders and price will ebb and flow with sentiment etc... that is what im generally ok at reading from the charts and both Avacta and HEMO are at what I believe to be there respective support levels now and both are good buys if you want to take a bit of risk. If you don't, wait for news or to see price brake out of each respective range and trade in that direction. Thats my view FWIW.

P.s. I dont care how good or certain avacta or hemo is. Generally it is a very bad idea to have all your eggs in one basket. You should really consider that JHFH.. Only reason I say that is cos you appear to be a genuine and respectful bloke

Proving your ignorance once again Archbishop. Believe it or not I take great joy in the fact you dont understand what you're talking about 😂 weird how Avacta has more than double the market cap of HEMO eh?! 😉

Anyway, another one who claims to have filtered me but clearly hasn't. 🤡

How does someone get lucky by calling a buy at 180p before it happens, then on way up managing to correctly see a pullback was coming caused by warrant issues that EVERYONE here assured me had already been forward sold. Buying that pullback and not assuming like many twitter traders did that the rise was over and then sell 30k worth right near the top before saying at 1600p this would most likely fall back to around 1000p support...

Awfully " lucky" or capable of putting fundamentals and technicals together and make money from it consistently?

No he doesn't copy all, just selective posts which suit him.

What he fails to mention was that at the time of posting that lot, HEMO was 7m market cap and falling. There was zero volume, zero interest in the stock, endless warrants being issued and cash needed. The chart looked horrendous and I felt like the company could go bust or be taken private. With the information at the time publicly available that was a logical conclusion. What I did go on to say though was that I loved the technology and IF funding got sorted and/or price broke above 180p with volume then I would buy the stock. As it happens both those things happened and I brought at probably the best point there has been here ever and the LTH's hate it. Especially because I then went on to sell half my holding at 1600p so now sat on a completely free ride with an average price to dream of. You see its for that reason I feel I can be balanced and not been to over egg everything. Im not desperately underwater like many of these STILL are. That's why there salty and keep spreadsheets with select comments on lol

JHFH, ive said this is really promising but far from being the slam dunk a lot of you are making out it is. I mean, where are all the deals from NYC & DC ?

Where is all the congress insiders dealing?

Why is this not valued at £24 already given it conclusively works?

Where is our big pharma partner or a takeover offer?

HEMO are not there yet. Need more data and time. Saying that appears controversial for this board showing just how far removed from reality most posts are.

Anyway, as I said earlier, next news sends this one way or the other... hopefully upwards!

Digitt, it was only in an earlier post that I praised the CEO and his ability to find workarounds AND I commented on him being a excellent scientist. You either missed that or ignored it as it doesn't suit your agenda to paint me as someone that hates him. I think hes a great scientist, highly conscientious and clearly capable of finding workarounds to problems. He's not a CEO though in my opinion.